Institutional Ownership Harmony Biosciences Holdings, Inc. (HRMY)
This table provides information about the institutional ownership of Harmony Biosciences Holdings, Inc. (HRMY). We have compiled data on the 242 institutions that hold shares in the stock, with a total of 45.2 Million shares, which have been reported (via 13F filing form) to have a value of $1.47 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Valor Management LLC
Chicago, IL |
Nov 12, 2024 Q3 2024 |
11,218,033
shares
|
$368 Million
100.0% of portfolio
|
Q4 2021
New holding
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
5,835,243
shares
|
$191 Million
0.0% of portfolio
|
Q2 2024
Reduced 1.48%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
3,471,247
shares
|
$114 Million
0.0% of portfolio
|
Q3 2024
Reduced 1.37%
|
|
|
Vivo Capital, LLC
Palo Alto, CA |
Nov 13, 2024 Q3 2024 |
2,606,247
shares
|
$85.5 Million
15.24% of portfolio
|
Q4 2022
Reduced 23.35%
|
|
|
Pacer Advisors, Inc.
Malvern, PA |
Nov 12, 2024 Q3 2024 |
1,928,336
shares
|
$63.2 Million
0.18% of portfolio
|
Q3 2024
Reduced 23.16%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
1,240,598
shares
|
$40.7 Million
0.0% of portfolio
|
Q3 2024
Reduced 2.58%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 07, 2024 Q3 2024 |
1,052,539
shares
|
$34.5 Million
0.01% of portfolio
|
Q3 2024
Added 10.01%
|
|
|
American Century Companies Inc
Kansas City, MO |
Nov 12, 2024 Q3 2024 |
856,464
shares
|
$28.1 Million
0.02% of portfolio
|
Q3 2024
Added 25.67%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
850,678
shares
|
$27.9 Million
0.0% of portfolio
|
Q3 2024
Added 1.74%
|
|
|
Lsv Asset Management
Chicago, IL |
Nov 12, 2024 Q3 2024 |
772,191
shares
|
$25.3 Million
0.07% of portfolio
|
Q3 2024
Added 33.54%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
735,418
shares
|
$24.1 Million
0.0% of portfolio
|
Q3 2024
Reduced 1.77%
|
|
|
Massachusetts Financial Services CO
Boston, MA |
Nov 12, 2024 Q3 2024 |
660,391
shares
|
$21.7 Million
0.01% of portfolio
|
Q3 2024
Added 27.07%
|
|
|
Ven Bio Partners LLC
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
614,594
shares
|
$20.2 Million
20.18% of portfolio
|
Q3 2024
Reduced 40.64%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Nov 13, 2024 Q3 2024 |
542,079
shares
|
$17.8 Million
0.05% of portfolio
|
Q3 2024
Added 3.15%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
492,600
shares
|
$16.2 Million
0.03% of portfolio
|
Q3 2024
Reduced 17.32%
|
|
|
Cutter Capital Management, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
376,315
shares
|
$12.3 Million
4.44% of portfolio
|
Q3 2024
Added 27.23%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
371,442
shares
|
$12.2 Million
0.0% of portfolio
|
Q3 2024
Reduced 0.87%
|
|
|
Nan Fung Group Holdings LTD
Central, K3 |
Nov 13, 2024 Q3 2024 |
368,665
shares
|
$12.1 Million
14.33% of portfolio
|
Q4 2022
Reduced 27.85%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2024 Q3 2024 |
355,949
shares
|
$11.7 Million
0.01% of portfolio
|
Q3 2024
Added 14.82%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 14, 2024 Q3 2024 |
350,641
shares
|
$11.5 Million
0.02% of portfolio
|
Q3 2024
Added 14.73%
|
|
|
Cambria Investment Management, L.P.
|
Nov 14, 2024 Q3 2024 |
331,551
shares
|
$10.9 Million
0.83% of portfolio
|
Q3 2024
New holding
|
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
Nov 14, 2024 Q3 2024 |
317,566
shares
|
$10.4 Million
0.01% of portfolio
|
Q3 2024
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
315,966
shares
|
$10.4 Million
0.0% of portfolio
|
Q3 2024
Added 11.52%
|
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
314,500
shares
|
$10.3 Million
3.5% of portfolio
|
Q3 2023
Reduced 44.87%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
308,013
shares
|
$10.1 Million
0.0% of portfolio
|
Q3 2024
Reduced 32.36%
|